Cancer predisposition is an evolving field in pediatrics. In this Q&A, Harry Lesmana, MD, discusses the advantages and challenges of integrating medical genetics into the care of pediatric oncology patients.
Bringing Novel Therapies to Patients With Pediatric Cancers
A new, early phase clinical trials program has launched at Cleveland Clinic Children’s. In this article, pediatric oncologist Matteo Trucco, MD, discusses the Cleveland Clinic Children’s Cancer Innovative Therapy Program.
Germline Genomic Profiles of Children, Adolescents and Young Adult with Solid Tumors Inform Management and Treatment
Researchers demonstrate the value of genetics evaluation and genetic testing in children, adolescents and young adults with solid tumors. Charis Eng, MD, PhD, gives insight into the largest-to-date evaluation of germline mutations in this population.
Managing Pediatric Oncology Patients During COVID-19
While much is still unknown, healthcare providers should give special consideration to managing pediatric oncology patients during the pandemic. In this article, pediatric hematologist/oncologist Seth Rotz, MD, discusses precautions and treatment considerations for this immunocompromised population.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Higher Risk of Low Bone Mineral Density and Fractures in Survivors of Childhood Hematologic Cancers
Survivors of childhood leukemia and lymphoma are at an increased risk of reduced bone mineral density. In this article, pediatric hematologist-oncologists discuss a recent study that identifies risks associated with reduced bone density in this population.
Preserving Fertility in Pediatric Cancer Patients
With advances in pediatric cancer treatment routinely enabling long-term survival, counseling young patients and their families before treatment about infertility risk and preservation strategies is essential.
Early Identification and Management of Pediatric Patients with Malignancy at Increased Cardiovascular Risk
Chemotherapy with anthracyclines and radiation therapy have significantly improved survival outcomes for children with many forms of cancer. Yet the effectiveness of these treatments can come at a high cost to the heart. Pediatric oncologist Seth Rotz, MD, and cardiologist Shahnawaz Amdani, MD, discuss how they screen for and manage cardiac complications during treatment for pediatric cancer.
Cleveland Clinic Children’s Among Nation’s Best Children’s Hospitals
Cleveland Clinic Children’s is dedicated to delivering the highest quality medical care, for every care in the world. To mark this continued advancement, this post focuses on specialty outcomes measures.
Virtual Visits Facilitate Health and Wellness During Pediatric and AYA Cancer Treatment
Virtual visits can increase access without overburdening staff. Pediatric hematologist/oncologist Peter Anderson, MD, discusses how he prepares for and organizes these virtual visits to optimize health and wellness in pediatric or AYA patients with cancer and their families.
The Changing Landscape of Pediatric Cancer Survivorship
Today, more children are surviving cancer than ever before. But now, increasing efforts are needed to detect and treat late effects as early as possible.